Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 52, 2017 - Issue 5
Submit an article Journal homepage
292
Views
10
CrossRef citations to date
0
Altmetric
Original Article

INF-free sofosbuvir-based treatment of post-transplant hepatitis C relapse – a Swedish real life experience

Castedal MariaThe Transplant Institute, Sahlgrenska University Hospital, Institution of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden;
,
Segenmark MichaelDepartment of Medicine, Division of Infectious Diseases, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
,
Cederberg SusanneDepartment of Medicine, Division of Infectious Diseases, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
,
Skoglund CatarinaThe Transplant Institute, Sahlgrenska University Hospital, Institution of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden;
&
Weiland OlaDepartment of Medicine, Division of Infectious Diseases, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, SwedenCorrespondence[email protected]
Pages 585-588 | Received 23 Nov 2016, Accepted 11 Jan 2017, Published online: 13 Feb 2017

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Maheeba Abdulla, Hamed Ali, Hafsa Nass, Jawad Khamis & Jehad AlQamish. (2019) Efficacy of direct-acting antiviral therapy for hepatitis C viral infection. Real-life experience in Bahrain. Hepatic Medicine: Evidence and Research 11, pages 69-78.
Read now
Sebastian Bernuth, Daniel Grimm, Johanna Vollmar, Felix Darstein, Jens Mittler, Michael Heise, Maria Hoppe-Lotichius, Peter R Galle, Hauke Lang & Tim Zimmermann. (2017) Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort. Drug Design, Development and Therapy 11, pages 2131-2138.
Read now

Articles from other publishers (8)

Sefora Castelletti, Maria Di Pietrantonio, Gianluca Morroni, Alessandro Fiorentini, Marco Tomasetti, Stefano Gemini, Alessio Ortolani, Gianluca Svegliati Baroni, Alessandra Riva & Lucia Brescini. (2019) Therapy with Direct-Acting Antiviral Agents in Transplanted Patients with HCV Recurrence: A Retrospective Analysis. Hepatitis Monthly 19:7.
Crossref
Alexandra L. Bixby, Linda Fitzgerald, Rachael Leek, Jessica Mellinger, Pratima Sharma & Sarah Tischer. (2019) Impact of direct‐acting antivirals for hepatitis C virus therapy on tacrolimus dosing in liver transplant recipients. Transplant Infectious Disease 21:3.
Crossref
Alexandre Araujo, Vanessa Valenzuela-Granados, Antonio B. Lopes, Matheus T. Michalczuk, Augusto Mantovani & Mario R. Alvares-da-Silva. (2019) Sofosbuvir-based antiviral therapy in patients with recurrent HCV infection after liver transplant: A real-life experience. Annals of Hepatology 18:3, pages 450-455.
Crossref
Catarina Skoglund, Martin Lagging & Maria Castedal. (2019) No need to discontinue hepatitis C virus therapy at the time of liver transplantation. PLOS ONE 14:2, pages e0211437.
Crossref
Eva M. Teegen, Michael Dürr, Max M. Maurer, Franziska Eurich, Antonia Vollbort, Brigitta Globke, Marcus Bahra, Hendrik Blaeker, Johann Pratschke & Dennis Eurich. (2018) Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct‐acting antivirals: Therapy of HCV‐recurrence. Transplant Infectious Disease 21:1.
Crossref
Antonio Di Biagio, Lucia Taramasso & Giovanni Cenderello. (2018) Treatment of hepatitis C virus genotype 4 in the DAA era. Virology Journal 15:1.
Crossref
P. Frisk, K. Aggefors, T. Cars, N. Feltelius, S. A. Loov, B. Wettermark & O. Weiland. (2018) Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden. European Journal of Clinical Pharmacology 74:7, pages 971-978.
Crossref
Y. O. SHULPEKOVA, N. V. SHULPEKOVA, M. C. SEMENISTAYA, A. A. USANOVA & C. S. PAVLOV. (2017) TREATMENT OF HCV INFECTION BY A COMBINATION OF SOFOSBUVIR AND DACLATASVIR. Medical Council:4, pages 36-41.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.